64 related articles for article (PubMed ID: 33569988)
1. MDMX/MDM4 is highly expressed and contributes to cell growth and survival in anaplastic large cell lymphoma.
Sinatkas V; Stathopoulou K; Xagoraris I; Ye J; Vyrla D; Atsaves V; Leventaki V; Medeiros LJ; Rassidakis GZ; Drakos E
Leuk Lymphoma; 2021 Jul; 62(7):1563-1573. PubMed ID: 33569988
[TBL] [Abstract][Full Text] [Related]
2. Molecular Screening in Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma: Anaplastic Lymphoma Kinase Analysis, Next-Generation Sequencing Fusion Gene Detection, and T-Cell Receptor Immunoprofiling.
Kalinova M; Mrhalova M; Kabickova E; Svaton M; Skotnicova A; Prouzova Z; Krenova Z; Kolenova A; Divoka M; Fronkova E; Kodet R
Mod Pathol; 2024 Mar; 37(3):100428. PubMed ID: 38266918
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic efficacy of the bromodomain inhibitor OTX015/MK-8628 in ALK-positive anaplastic large cell lymphoma: an alternative modality to overcome resistant phenotypes.
Boi M; Todaro M; Vurchio V; Yang SN; Moon J; Kwee I; Rinaldi A; Pan H; Crescenzo R; Cheng M; Cerchietti L; Elemento O; Riveiro ME; Cvitkovic E; Bertoni F; Inghirami G;
Oncotarget; 2016 Nov; 7(48):79637-79653. PubMed ID: 27793034
[TBL] [Abstract][Full Text] [Related]
4. Analysis and therapeutic targeting of the IL-1R pathway in anaplastic large cell lymphoma.
Song Z; Wu W; Wei W; Xiao W; Lei M; Cai KQ; Huang DW; Jeong S; Zhang JP; Wang H; Kadin ME; Waldmann TA; Staudt LM; Nakagawa M; Yang Y
Blood; 2023 Oct; 142(15):1297-1311. PubMed ID: 37339580
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA mitophagy and ALK-negative anaplastic lymphoma-associated transcript: a novel regulator of mitophagy in T-cell lymphoma.
Mularoni V; Donati B; Tameni A; Manicardi V; Reggiani F; Sauta E; Zanelli M; Tigano M; Vitale E; Torricelli F; Ascani S; Martino G; Inghirami G; Sanguedolce F; Ruffini A; Bavieri A; Luminari S; Pizzi M; Dei Tos AP; Fesce C; Neri A; Ciarrocchi A; Fragliasso V
Haematologica; 2023 Dec; 108(12):3333-3346. PubMed ID: 37381763
[TBL] [Abstract][Full Text] [Related]
6. Detection of TRAF1-ALK fusion in skin lesions of systemic ALK+ anaplastic large cell lymphoma initially involving the skin and the draining lymph node.
Norimatsu Y; Akatsuka T; Matsuoka A; Hamada T; Mori I; Shiomi T; Mori N; Onishi K; Togashi Y; Inoue N; Takeuchi K; Sugaya M
J Dermatol; 2024 Jan; 51(1):120-124. PubMed ID: 37753577
[TBL] [Abstract][Full Text] [Related]
7. ALK-negative CNS anaplastic large cell lymphoma: case report and review of literature.
Lannon M; Lu JQ; Chum M; Wang BH
Br J Neurosurg; 2023 Oct; 37(5):1245-1250. PubMed ID: 33253051
[TBL] [Abstract][Full Text] [Related]
8. Chimeric kinase ALK induces expression of NAMPT and selectively depends on this metabolic enzyme to sustain its own oncogenic function.
Zhang Q; Basappa J; Wang HY; Nunez-Cruz S; Lobello C; Wang S; Liu X; Chekol S; Guo L; Ziober A; Nejati R; Shestov A; Feldman M; Glickson JD; Turner SD; Blair IA; Van Dang C; Wasik MA
Leukemia; 2023 Dec; 37(12):2436-2447. PubMed ID: 37773266
[TBL] [Abstract][Full Text] [Related]
9. STAT3 couples activated tyrosine kinase signaling to the oncogenic core transcriptional regulatory circuitry of anaplastic large cell lymphoma.
Prutsch N; He S; Berezovskaya A; Durbin AD; Dharia NV; Maher KA; Matthews JD; Hare L; Turner SD; Stegmaier K; Kenner L; Merkel O; Look AT; Abraham BJ; Zimmerman MW
Cell Rep Med; 2024 Mar; 5(3):101472. PubMed ID: 38508140
[TBL] [Abstract][Full Text] [Related]
10. ALK-negative anaplastic large cell lymphoma with JAK2 rearrangement mimicking classic Hodgkin lymphoma.
Jaye DL; Feldman AL
Blood; 2023 Apr; 141(17):2160. PubMed ID: 37103947
[No Abstract] [Full Text] [Related]
11. Comparison of two immunohistochemical staining protocols for ALK demonstrates non-inferiority of a 5A4 clone-based protocol versus an ALK01 clone-based protocol for the diagnosis of ALK + anaplastic large cell lymphoma.
Fernandez-Pol S; Ferreira CR; Manohar V; Sanches JA; Lage LAPC; Pereira J; Zerbini MCN; Gratzinger D; Natkunam Y
J Hematop; 2023 Mar; 16(1):1-5. PubMed ID: 38175372
[TBL] [Abstract][Full Text] [Related]
12. Self-Assembled Aptamer-Nanomedicine for Targeted Chemotherapy and Gene Therapy.
Zhao N; Zeng Z; Zu Y
Small; 2018 Jan; 14(4):. PubMed ID: 29205808
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive genomic analysis reveals molecular heterogeneity in pediatric ALK-positive anaplastic large cell lymphoma.
Shaw TI; Pounds S; Cao X; Ma J; Palacios G; Mason J; Perkins S; Wu G; Fan Y; Wang J; Zhou X; Obermayer A; Kinney MC; Kraveka J; Gross T; Sandlund J; Zhang J; Mullighan C; Lim MS; Leventaki V
Res Sq; 2024 Mar; ():. PubMed ID: 38585847
[TBL] [Abstract][Full Text] [Related]
14. Teaching NeuroImage: Branching Dura Mater in Primary CNS ALK-Positive Anaplastic Large Cell Lymphoma.
Rattanawong W; Tekarnjnavanit A; Marukatat C; Hemachudha P; Pongpitakmetha T; Anukoolwittaya P
Neurology; 2023 Oct; 101(17):766-768. PubMed ID: 37536956
[No Abstract] [Full Text] [Related]
15. Targeting Autophagy in ALK-Associated Cancers.
Frentzel J; Sorrentino D; Giuriato S
Cancers (Basel); 2017 Nov; 9(12):. PubMed ID: 29186933
[TBL] [Abstract][Full Text] [Related]
16. Primary Anaplastic-Lymphoma-Kinase-Positive Large-Cell Lymphoma of the Central Nervous System: Comprehensive Review of the Literature.
Colamaria A; Leone A; Carbone F; Dallos Laguado YA; Fochi NP; Sacco M; Fesce C; Sanguedolce F; Giordano G; Iaconetta G; Spetzger U; Coppola L; De Santis E; Coppola G; De Notaris M
J Clin Med; 2023 Dec; 12(24):. PubMed ID: 38137585
[TBL] [Abstract][Full Text] [Related]
17. The p53 activator overcomes resistance to ALK inhibitors by regulating p53-target selectivity in ALK-driven neuroblastomas.
Miyazaki M; Otomo R; Matsushima-Hibiya Y; Suzuki H; Nakajima A; Abe N; Tomiyama A; Ichimura K; Matsuda K; Watanabe T; Ochiya T; Nakagama H; Sakai R; Enari M
Cell Death Discov; 2018; 4():56. PubMed ID: 29760954
[TBL] [Abstract][Full Text] [Related]
18. Systemic ALK-positive anaplastic large cell lymphoma with bilateral optic neurolymphomatosis resulting in permanent blindness.
Seegobin K; Alhaj Moustafa M; Fischer D; Keller K; Hastings J; Kharfan-Dabaja MA; Ayala E; Gupta V; Tun HW; Jiang L
Clin Case Rep; 2020 Dec; 8(12):2629-2633. PubMed ID: 33363793
[TBL] [Abstract][Full Text] [Related]
19. Occult ALK-negative anaplastic large cell lymphoma complicating chronic lymphocytic leukemia.
Ahmed R; Feldman AL
Blood; 2024 Mar; 143(10):938. PubMed ID: 38451510
[No Abstract] [Full Text] [Related]
20. Kemps PG, Picarsic J, Durham BH, et al. ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition. Blood. 2022;139(2):256-280.
Blood; 2023 Jun; 141(22):2785-2786. PubMed ID: 37261851
[No Abstract] [Full Text] [Related]
[Next] [New Search]
